The clinical impact of infection with swine flu (H1N109) strain of influenza virus in hematopoietic stem cell transplant recipients

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 1, 2011, Pages 147-153

  George, Biju ^a   Ferguson, Patricia ^a   Kerridge, Ian ^a   Gilroy, Nicole ^a   Gottlieb, David ^a   Hertzberg, Mark ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

H1N109 infection; Stem cell transplant

Indexed keywords

OSELTAMIVIR; ZANAMIVIR;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOWER RESPIRATORY TRACT INFECTION; MALE; MEDICAL RECORD REVIEW; NEUTROPENIA; PNEUMONIA; RETROSPECTIVE STUDY; SURVIVAL; SWINE INFLUENZA; UPPER RESPIRATORY TRACT INFECTION; VIRUS REACTIVATION; ANIMAL; INFLUENZA; MIDDLE AGED; ORTHOMYXOVIRUS; RESPIRATORY TRACT DISEASE; SWINE; VIROLOGY;

ADULT; ANIMALS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NEUTROPENIA; ORTHOMYXOVIRIDAE; OSELTAMIVIR; RESPIRATORY TRACT DISEASES; RETROSPECTIVE STUDIES; SWINE;

EID: 79955965090     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.07.004     Document Type: Article

References (20)

1. Bishop JF, Murnane MP, Owen R. Australia's winter with the 2009 Pandemic Influenza A (H1N1) virus. N Engl J Med. 2009;361:2591-2594.
2. Webb SA, Pettilä V, Seppelt I, et al. (The ANZIC influenza investigators). Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med. 2009;361:1925-1934.
3. Jain S, Kamimoto L, Bramley AM, et al. Hospitalised patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009;361:1935-1944.
4. Schiffer JT, Kirby K, Sandmaier B, Storb R, Corey L, Boeckh M. Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopietic stem cell transplantation. Haematologica. 2009;24:1101-1108.
5. Boeckh M. The challenge of respiratory virus infections in hematopoietic cell transplant recipients. Br J Haematol. 2008; 143:455-467.
6. Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality and vaccine responses. Lancet Infect Dis. 2009;9:493-504.
7. Casper C, Englund J, Boeckh M. How we treat influenza in patients with hematologic malignancies. Blood. 2009 [Epub ahead of print; DOI:10.1182/blood-2009-11-255455].
8. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309-332.
9. Kok J, Blyth CC, Foo H, et al. Comparison of a rapid antigen test with nucleic acid testing during cocirculation of pandemic influenza A/H1N1 2009 and seasonal influenza A/H3N2. J Clin Micro. 2010;48:290-291.
10. Hancock K, Veguilla V, Lu X, et al. Cross- reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361:1945-1952.
11. Morens DM, Taubenberger JK, Fauci AS. The persistent legacy of the 1918 influenza virus. N Engl J Med. 2009;361:225-229.
12. Chemaly RF, Ghosh S, Bodey GP, et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore). 2006;85:278-287.
13. Khanna N, Steffen I, Studt JD, et al. Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2009;11:100-105.
14. Ljungman P. Respiratory virus infections in stem cell transplant patients: the European experience. Biol Blood Marrow Transplant. 2001;7(Suppl):5S-7S.
15. Kharfan-Dabaja MA, Velez A, Richards K, et al. Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic stem cell transplantation: a potentially catastrophic problem in a vunerable population. Int J Hematol. 2010;91:124-127.
16. Redelman-Sidi G, Sepkowitz KA, Huang CK, et al. 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect. 2010;60:257-263.
17. Bastos DA, Rodrigues CA, Patah P, et al. Influenza A H1N1 virus infection in two hematopoietic stem cell transplant recipients. Blood. 2009;114:22. Abstract 1169.
18. Jefferson T, Del Mar C, Dooley L, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ. 2009;339:b3675.
19. Vu D, Peck AJ, Nichols WG, et al. Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study. Clin Infect Dis. 2007; 45:187-193.
20. Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis. 2004;39:1300-1306.